Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Journal of the American Academy of Dermatology|September 18, 2013
Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literatureGaelle Quéreux, Anabelle Brocard, Mélanie Saint-Jean, et al.BMC Research Notes|July 27, 2017
Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case reportGaelle Quéreux, Guillaume Herbreteau, Anne-Chantal Knol, et al.Journal of Immunology Research|April 18, 2014
Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survivalAmir Khammari, Anne-Chantal Knol, Jean-Michel Nguyen, et al.Experimental Dermatology|November 28, 2017
BRAF mutations might be more common than supposed in vulvar melanomasSophie Wylomanski, Marc G Denis, Sandrine Théoleyre, et al.Cancers|July 16, 2020
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma PatientsGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.Plos One|January 4, 2013
Tissue biomarkers in melanoma patients treated with TILAnne-Chantal Knol, Jean-Michel Nguyen, Marie-Christine Pandolfino, et al.Oncology Reports|June 14, 2014
Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patientsMelanie Saint-Jean, Gaëlle Quereux, Jean-Michel Nguyen, et al.Acta Dermato-Venereologica|November 22, 2016
Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant RecipientsAnabelle Brocard, Anne-Chantal Knol, Céline Bossard, et al.Cancer Immunology, Immunotherapy : CII|April 20, 2020
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trialAmir Khammari, Jean-Michel Nguyen, Marie-Thérèse Leccia, et al.Cancer Immunology, Immunotherapy : CII|April 8, 2015
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patientsAmir Khammari, Jean-Michel Nguyen, Melanie Saint-Jean, et al.Pageof 5